DekaBank Deutsche Girozentrale - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$1,468,000
+51.0%
62,8000.0%0.01%
+42.9%
Q1 2018$972,000
-21.0%
62,800
-27.8%
0.01%
-30.0%
Q4 2017$1,231,0000.0%87,0000.0%0.01%0.0%
Q3 2017$1,231,000
-18.3%
87,0000.0%0.01%
-16.7%
Q2 2017$1,506,000
+2021.1%
87,000
+2383.6%
0.01%
+1100.0%
Q2 2016$71,000
+57.8%
3,503
+110.4%
0.00%0.0%
Q1 2016$45,000
-99.0%
1,665
-96.2%
0.00%
-98.1%
Q4 2015$4,519,000
-44.4%
44,188
-3.1%
0.05%
-47.5%
Q3 2015$8,129,000
+1.5%
45,584
+26.5%
0.10%
+4.2%
Q2 2015$8,012,000
+8.9%
36,028
-2.5%
0.10%
+3.3%
Q1 2015$7,354,000
+37.6%
36,970
-1.1%
0.09%
+37.3%
Q4 2014$5,345,000
+24.7%
37,373
+14.3%
0.07%
+15.5%
Q3 2014$4,286,000
+16.8%
32,711
+12.5%
0.06%
+5.5%
Q2 2014$3,668,000
-8.3%
29,082
-4.1%
0.06%
-14.1%
Q1 2014$4,001,000
+4.8%
30,320
-6.7%
0.06%
+1.6%
Q4 2013$3,816,000
-22.8%
32,487
-31.4%
0.06%
-27.6%
Q3 2013$4,940,00047,3480.09%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders